- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scancell Hldgs Plc (SCLP)
Scancell Hldgs Plc stock price live, this page displays LON SCLP stock exchange data. View the SCLP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Scancell Hldgs Plc real time stock price chart below.
What Is the Scancell Hldgs Plc Stock Price Today?
The Scancell Hldgs Plc stock price today is 9.75.
What Is the Stock Symbol for Scancell Hldgs Plc?
The stock symbol for Scancell Hldgs Plc is ""SCLP.""
What Stock Exchange Does Scancell Hldgs Plc Trade On?
Scancell Hldgs Plc is listed and trades on the London stock exchange.
Is Scancell Hldgs Plc a Good Stock to Buy?
Determining whether Scancell Hldgs Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCLP quote. (ISIN: GB00B63D3314)
What Is the Scancell Hldgs Plc Stock Price Today?
The Scancell Hldgs Plc stock price today is 9.75.
What Is the Stock Symbol for Scancell Hldgs Plc?
The stock symbol for Scancell Hldgs Plc is ""SCLP.""
What Stock Exchange Does Scancell Hldgs Plc Trade On?
Scancell Hldgs Plc is listed and trades on the London stock exchange.
Is Scancell Hldgs Plc a Good Stock to Buy?
Determining whether Scancell Hldgs Plc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCLP quote. (ISIN: GB00B63D3314)
London
Currency in GBP
9.75
+0.20(+2.09%)
Closed·
Fair Value
An estimate of a Scancell's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.25
10.00
52 wk Range
7.26
18.00
SCLP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Scancell's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.2510.00
52 wk Range
7.2618.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
SCLP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Scancell's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
31.00
Upside
+217.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Scancell Hldgs Plc Company Profile
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom.
Compare SCLP to Peers and Sector
Metrics to compare | SCLP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCLPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.2x | −5.8x | −0.7x | |
PEG Ratio | −0.72 | −0.15 | 0.00 | |
Price/Book | −26.4x | 5.9x | 2.6x | |
Price / LTM Sales | 21.5x | 11.1x | 3.4x | |
Upside (Analyst Target) | 217.9% | 81.9% | 37.6% | |
Fair Value Upside | Unlock | 12.8% | 4.6% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.00
(+217.95% Upside)
Earnings
Latest Release
Sep 11, 2025
EPS / Forecast
-- / --
Revenue / Forecast
4.71M / --
FAQ
What Stock Exchange Does Scancell Trade On?
Scancell is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Scancell?
The stock symbol for Scancell is "SCLP."
What Is the Scancell Market Cap?
As of today, Scancell market cap is 101.18M.
What Is Scancell's Earnings Per Share (TTM)?
The Scancell EPS (TTM) is -0.01.
When Is the Next Scancell Earnings Date?
Scancell will release its next earnings report on 10 Sept 2025.
From a Technical Analysis Perspective, Is SCLP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Scancell Stock Split?
Scancell has split 6 times.
How Many Employees Does Scancell Have?
Scancell has 60 employees.
What is the current trading status of Scancell (SCLP)?
As of 25 Oct 2025, Scancell (SCLP) is trading at a price of 9.75, with a previous close of 9.55. The stock has fluctuated within a day range of 9.25 to 10.00, while its 52-week range spans from 7.26 to 18.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.